I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

July 31, 2016

Conditions
Healthy VolunteersAlzheimer DiseaseMolecular Imaging
Interventions
RADIATION

[11C]BU99008

Baseline Scan, Test-ReTest or Dosimetry

DRUG

Idazoxan

Idazoxan block of \[11C\]BU99008

DRUG

Isocarboxazid

Isocarboxazid block of \[11C\]BU99008

Trial Locations (1)

W12 0NN

Centre for Neuropsychopharmacology; Division of Brain Sciences; Imperial College London; Burlington Danes Building; Hammersmith Hospital campus; 160 Du Cane Road, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Imperial College London

OTHER

NCT02323217 - I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers | Biotech Hunter | Biotech Hunter